Here Are 3 Notable Pharma Stocks That Could Top Third-Quarter Estimates [Investor's Business Daily]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Investors Business Daily
Related news 4:18 PM ET Animal-health leader Zoetis said Thursday Kristin Peck will succeed Juan Ramon Alaix as the pharma company's chief executive officer. Peck... BMY Stock Plus Celgene Will Be A Top 5 Pharma — But Should You Buy It? AbbVie Stock Is Poised To Become A Top 5 Pharma — But Should You Buy It? JNJ Stock Gets A Boost After Settling Opioid Cases — But Should You Buy It? Pfizer Stock Is A Top Pharma Company — But Should You Buy It? Biogen Stock Flailed On Alzheimer's Flop — Is This Biotech Stock A Buy Now? Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Looking For Growth? Take A Look At These Biotechnology Stocks Why This Biotech Stock Just Broke Out In Bullish Volume — And Another Toppled Pharmaceutical companies Allergan ( AGN ), Bristol-Myers Squibb ( BMY ) and Zoetis ( ZTS ) could top the Street's third-quarter earnings expectations, an analyst said Thursday. But of the trio, UBS analyst Navin Jacob only
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck raises 2024 profit forecast on strong cancer, HPV drugs sales [Yahoo! Finance]Yahoo! Finance
- Merck Announces First-Quarter 2024 Financial ResultsBusiness Wire
- Immutep reports promising efti/Keytruda data for head and neck cancer [Seeking Alpha]Seeking Alpha
- Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday? [Yahoo! Finance]Yahoo! Finance
- Oncology Market Expected to Grow at 9.6% CAGR, Reaching USD 533.2 Bn by 2032 | DMR [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 2/1/24 - Beat
MRK
Sec Filings
- 4/11/24 - Form ARS
- 4/11/24 - Form DEFA14A
- 4/11/24 - Form DEF
- MRK's page on the SEC website